Dr. Marlo O. Van Steyn, MD

Dr. Van Steyn practices at Ohio Orthopedic Surgery Institute in Columbus, Ohio.

Dr. Van Steyn's NPI, 1003030040, was assigned on April 12, 2007. Dr. Van Steyn graduated from Wright State University Boonshoft School of Medicine in 2003. Dr. Van Steyn holds Ohio license 35-088935.

Dr. Van Steyn's primary practice is Ohio Orthopedic Surgery Institute, at 4605 Sawmill Road, Columbus, OH 43220. The practice phone is (614) 827-8777.

Dr. Van Steyn's primary practice is Ohio Orthopedic Surgery Institute in Columbus, Ohio. Dr. Van Steyn is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is Orthopedic One. Dmand AI also links Dr. Van Steyn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Steyn practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Van Steyn's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Van Steyn is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Van Steyn is licensed in Ohio.

CMS data shows 2,006 Medicare services from Dr. Van Steyn across 22 procedure codes in 2024, for 592 Medicare patients. Medicare paid $160,264 for them.

CMS counts 592 Medicare patients who saw Dr. Van Steyn in 2024. The largest group is 65 to 74, with 343 patients. 74% of them have arthritis, and 73% have high cholesterol. 2% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Steyn's median patient age at 68, with 64% women.

In 2024, Dr. Van Steyn wrote 155 Medicare Part D claims for 109 patients. 99% of them were for generic drugs. CMS names the drug for 102 of them, across 5 drugs with 11 or more claims each, at $251 in total drug cost. In 2023, CMS named 70 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Van Steyn for performance year 2024, reported as part of a group. Dr. Van Steyn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Van Steyn in 2014. Dr. Van Steyn's most frequent co-authors are David C. Flanigan, MD, Michael William Mariscalco, MD and Jonathan Patrick Smerek, MD.

Dmand AI links Dr. Van Steyn to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 6 general payments to Dr. Van Steyn from 4 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Smith & Nephew, Inc. paid the most, $125.

Dr. Van Steyn graduated from Wright State University Boonshoft School of Medicine in 2003.